ID   TC-212
AC   CVCL_S867
SY   TC212
DR   Wikidata; Q54971799
RX   CelloPub=CLPUB00569;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Derived from site: Metastatic; Testis; UBERON=UBERON_0000473.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 11,14
ST   D18S51: 12,16
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 19,20
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 10,11
ST   FGA: 20,24
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
RX   CelloPub=CLPUB00569;
RA   Dickman P.S., Tsokos M.G., Triche T.J.;
RT   "Biology of rhabdomyosarcoma: cell culture, xenografts, and animal
RT   models.";
RL   (In) Rhabdomyosarcoma and related tumors in children and adolescents; Maurer H.M., Ruymann F.B., Pochedly C.E. (eds.); pp.49-88; CRC Press; Boca Raton (1991).
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.;
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183;
RA   Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G.,
RA   Linardic C.M.;
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//